SCHEMBL1237286

SCHEMBL1237286

CCOP(=O)(OCC)OC(C)=O

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.57
ALDH1A1 P00352 3/20 0.42
LMNA P02545 2/20 0.42
HSD17B10 Q99714 1/20 0.42
TDP1 Q9NUW8 2/20 0.40
TP53 P04637 1/20 0.40
PPARD Q03181 2/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
MEN1 O00255 1/20 0.36
NR1I2 O75469 1/20 0.36
KMT2A Q03164 1/20 0.36
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28101148 0.98 TSHR (0.55) TSHRALDH1A1LMNAHSD17B10TDP1
SCHEMBL11122982 0.95 TSHR (0.57) TSHRALDH1A1LMNAHSD17B10TDP1
Trimethylammonium SCHEMBL28541031 0.91 TSHR (0.48) TSHRALDH1A1LMNAHSD17B10TDP1
SCHEMBL28743332 0.89 TSHR (0.46) TSHRALDH1A1LMNAHSD17B10TDP1
SCHEMBL9007352 0.89 TSHR (0.50) TSHRALDH1A1LMNAHSD17B10TDP1
SCHEMBL16055939 0.86 CYP3A4 (0.57) TSHRALDH1A1CYP3A4
SCHEMBL8974193 0.84 TSHR (0.41) TSHRALDH1A1LMNAHSD17B10TDP1
SCHEMBL8104926 0.83 TSHR (0.44) TSHRALDH1A1LMNAHSD17B10TDP1
SCHEMBL6061683 0.82 TSHR (0.43) TSHRALDH1A1LMNAHSD17B10TDP1
Triethyl Phosphate SCHEMBL10358522 0.81 TSHR (0.77) TSHRALDH1A1LMNAHSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240383912-A1 NOVEL METHOD FOR SYNTHESIZING DECURSIN DERIVATIVE PRG S&TECH INC. (KR) 2024-11-21 US claimed
EP-4414367-A1 NOVEL METHOD FOR SYNTHESIZING DECURSIN DERIVATIVE PRG S&Tech Inc. (KR) 2024-08-14 EP claimed
CN-118076611-A New method for synthesizing decursin derivatives PRG科技株式会社 2024-05-24 CN claimed
US-20230378539-A1 SECONDARY BATTERY, METHOD FOR PREPARING SECONDARY BATTERY, BATTERY MODULE, BATTERY PACK, AND ELECTRICAL APPARATUS CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) 2023-11-23 US claimed
EP-4276964-A1 SECONDARY BATTERY, METHOD FOR PREPARING SECONDARY BATTERY, BATTERY MODULE, BATTERY PACK, AND POWER CONSUMPTION APPARATUS Contemporary Amperex Technology Co., Limited (CN) 2023-11-15 EP claimed
WO-2023082869-A1 SECONDARY BATTERY, METHOD FOR PREPARING SECONDARY BATTERY, BATTERY MODULE, BATTERY PACK, AND POWER CONSUMPTION APPARATUS 宁德时代新能源科技股份有限公司 2023-05-19 WO claimed
CN-116111178-A Secondary battery, method for manufacturing secondary battery, battery module, battery pack, and electricity using device 宁德时代新能源科技股份有限公司 2023-05-12 CN claimed
WO-2023058875-A1 NOVEL METHOD FOR SYNTHESIZING DECURSIN DERIVATIVE (주)피알지에스앤텍 2023-04-13 WO claimed
CN-108918859-B Method for simultaneously detecting methyl parathion, chlorpyrifos and trichlorfon based on quantum dot labeled bionic fluorescence immunoassay 山东农业大学 2021-05-18 CN claimed
WO-2014001939-A1 PROCESS FOR PREPARATION OF AGOMELATINE AND CRYSTALLINE FORM I THEREOF ALEMBIC PHARMACEUTICALS LIMITED (IN) 2014-01-03 WO claimed
WO-2011064790-A1 A NOVEL PROCESS FOR MAKING ALISKIREN, ITS NOVEL INTERMEDIATES AND CERTAIN NOVEL COMPOUNDS Avra Laboratories Pvt. Ltd (IN) 2011-06-03 WO claimed
CN-122025690-A Composite modified material of high-toughness graphite bipolar plate and preparation method thereof 青岛高等密封制品有限公司 2026-05-12 CN disclosed
CN-116111178-B Secondary battery, method for manufacturing secondary battery, battery module, battery pack, and electricity using device 宁德时代新能源科技股份有限公司 2025-09-30 CN disclosed
US-20240383912-A1 NOVEL METHOD FOR SYNTHESIZING DECURSIN DERIVATIVE PRG S&TECH INC. (KR) 2024-11-21 US disclosed
EP-4414367-A1 NOVEL METHOD FOR SYNTHESIZING DECURSIN DERIVATIVE PRG S&Tech Inc. (KR) 2024-08-14 EP disclosed
US-4267267-A HAVING A SUBBING LAYER OF A COPOLYMER OF VINYL CHLORIDE AND/OR VINYLIDENE CHLORIDE ON A GAS-PERBEABLE SUPPORT; STORAGE STABILITY FUJI PHOTO FILM CO., LTD. (JP) 1981-05-12 US disclosed
US-4264466-A LAUNDRY DETERGENTS THE PROCTER & GAMBLE COMPANY (US) 1981-04-28 US disclosed
US-4248928-A TETRAACETYL AKYLENEDIAMINES OR TETRAACETYL GLYCOURIL PEROXY BLEACH PRECURSOR THE PROCTER & GAMBLE COMPANY (US) 1981-02-03 US disclosed
US-4179390-A Laundry additive product THE PROCTER & GAMBLE COMPANY (US) 1979-12-18 US disclosed
US-4097477-A Steroid compounds and processes thereof STEELE CHEMICALS CO. LTD. (CA) 1978-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240383912-A1 NOVEL METHOD FOR SYNTHESIZING DECURSIN DERIVATIVE PRTN3, PARG, PLA2G12B TSHR 1480/4885ALDH1A1 1947/4885LMNA 795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.